Work

Clinical next generation sequencing (NGS) of esophagogastric (EG) adenocarcinomas identifies distinct molecular signatures of response to HER2 inhibition, first-line 5FU/platinum and PD1/CTLA4 blockade

Year: 2016

Type: article

Study design: Observational Study

Source: Annals of Oncology

DOI: 10.1093/annonc/mdw371.04

Authors: Y.Y. Janjigian, F. Sanchez-Vega, P. Jonsson, Y. Tuvy, N. Bouvier, J. Riches, R. Kundra, G. Ku, J.F. Hechtman, D. Kelsen, L. Tang, D. Ilson, E. Vakiani, Z. Stadler, M. Callahan, D.B. Solit, M.F. Berger, B.S. Taylor, N. Schultz

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Gastric Cancer Management and Outcomes

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2587915970

FWCI: 0.797

Cites:

Cited by: 4

Related to: 10